| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to psychiatry and dietology, and may be used for treating and improving quality of life in the patients with overweight, sleep disorders and obesity prevention. Body weigh index (BWI), sleep disorders (SD), affective disorders (AD), eating disorders (ED), dietary condition disorders (DCD), and actual nutrition disorders (AND) are assessed. There are prescribed in the patients: individual clinical nutrition taking into account body weigh index, dietary condition and actual nutrition, psychotherapist counselling with the participation of a nutrition specialist once a day for ten days. Then, the patient is counselled once a week for one month and takes up the antidepressant valdoxan considering the options. If the patient suffers mild and moderate sleep disorders and shows an emotive type of the eating behaviour combined with mild affective disorders, a single dose makes 25 mg a day for the night for 2 weeks. If the progression of the anxiety and depression level 2 weeks after the beginning of the therapy is considered to be positive, the dose is preserved to the end of the therapeutic course for three to 6 months. If no progression is exhibited, the dose is to be increased to 50 mg a day, and the therapy is continued from four to eight months. If the patient exhibits the severe sleep disorders, an emotive type of the eating behaviour combined with moderate affective disorders, the single dose makes 50 mg for the night for two-three months. If the patient suffers the sleep disorders, an emotive type of the eating behaviour combined with severe affective disorders, the patient is supposed to be treated by a district psychiatrist.EFFECT: treating and improving the quality of life in the patients with overweight, sleep disorders and preventing obesity.2 tbl, 2 ex |
